Fig. 01 -

Title Slide

Fig. 02 -

Document

Fig. 03 -

Disclosures

Fig. 04 -

Definition

Fig. 05 -

GOLD 2011 and 2017

Fig. 06 -

Special Communication

Fig. 07 -

Symptom Aspects

Fig. 08 -

GOLD 2011 and 2017 Cont.

Fig. 09 -

Symptom Aspects (Cont.)

Fig. 10 -

Study Design - COPDGene

Fig. 11 -

Emphysema and Gas Trapping - CT

Fig. 12 -

Study Design - Spiromics

Fig. 13 -

Results - Baseline CAT Score

Fig. 14 -

Smokers

Fig. 15 -

Airflow and Evidence

Fig. 16 -

Abnormalities

Fig. 17 -

Pathophysiological

Fig. 18 -

Risk Factors

Fig. 19 -

Biomass Fuel

Fig. 20 -

Biomass and Tobacco

Fig. 21 -

Host Factors

Fig. 22 -

FEV1 Trajectories

Fig. 23 -

FEV1 and COPD

Fig. 24 -

Different Categories

Fig. 25 -

Lung Function Trajectories

Fig. 26 -

Lung Function Pathways

Fig. 27 -

Exacerbations and Comorbidities

Fig. 28 -

Etiology, Pathobiology and Pathology

Fig. 29 -

Burden of Mortality

Fig. 30 -

Burden of Disability

Fig. 31 -

Estimates

Fig. 32 -

Key Points

Fig. 33 -

Key Points (Cont.)